In Summary
- Modern oncology creates the conditions for recovery, but the healing itself — immune surveillance, tissue repair, metabolic restoration — is carried out by the patient’s own body, which is why protecting that capacity matters as much as treating the tumor.
- “Coexistence over conquest” is a reframe that complements conventional oncology. It explicitly does not mean declining, delaying, or replacing evidence-based treatment.
- Sleep, nutrition, stress management, gentle activity, and constitutional support help preserve the biological reserves that recovery depends on through aggressive treatment phases.
- Treatment decisions belong with your oncology team. Korean medicine here is supportive and integrative — used alongside standard care, never as a substitute for it.
When a cancer diagnosis arrives, most patients and families instinctively look outward — to hospitals, imaging machines, chemotherapy protocols, and surgical suites. This response is rational. Modern oncology has achieved extraordinary things. But as a professor of Korean Medicine at Dongguk University specializing in pathology and oncology, I have spent many years watching what happens after the protocol ends. What I have observed consistently is this: the patients who recover well are not always those who received the most aggressive treatment. They are those whose bodies retained the capacity to heal.
This distinction — between eliminating disease and preserving the conditions for recovery — is the central argument of this article. It is not an argument against conventional oncology. It is an argument for expanding what we consider treatment to include.
1. The Biological Truth Oncology Rarely States Explicitly
Medical science extends life and reduces suffering. But here is the foundational truth that gets underemphasized in clinical consultations: medical interventions create the conditions for recovery. They do not perform the recovery itself. The actual work of healing — cellular repair, immune surveillance, tissue regeneration, metabolic restoration — is done entirely by the patient’s body.
This is not alternative medicine philosophy. It is basic biology. When we look at the largest historical gains in human longevity, they did not come from complex hospital procedures. They came from nutrition, sanitation, and vaccines — all of which work by strengthening or supporting the body’s innate biological resilience rather than replacing it.
The centenarian populations studied in longevity research are not characterized by frequent medical intervention. They are characterized by low chronic stress, nutritional adequacy, physical activity, and social connection — the ecological conditions under which the human body’s self-repair systems function optimally. This is not coincidence. It is physiology.
2. Why Cancer Requires a Different Philosophical Framework
To understand why I advocate for what I call Natural Healing and Cancer Coexistence, we first need to be precise about what cancer actually is — because the dominant metaphors we use to describe it lead to treatment decisions that are sometimes counterproductive.
Cancer is not an invasion. Unlike bacteria or viruses, cancer cells are not foreign organisms. They are the patient’s own cells, operating outside the regulatory constraints that normally govern cell division and specialization. A single cancer cell is not inherently lethal. What makes cancer dangerous is the disruption of proportion and function: when undifferentiated cells multiply without restraint, they crowd out the specialized tissues that keep organs functioning.
In the framework of Korean medicine, health is defined by harmonious proportion — what we call homeostasis in Western terms, and what classical texts describe as the balance of Yin, Yang, and Qi. Cancer is, in this sense, a profound loss of proportion within the body’s own biological community. It does not poison the host from outside. It displaces the host’s functional biology from within.
This distinction matters clinically. If cancer is an internal disruption rather than an external enemy, then treatment strategies modeled on warfare — search and destroy, maximum tolerated dose, total eradication — may, in some situations, be solving the right problem with tools that create a parallel problem.
3. The Paradox at the Core of Aggressive Oncology
I want to be careful here, because this point is frequently misunderstood. I am not arguing that chemotherapy or radiation is wrong — for many cancers they are the difference between life and death. I am arguing that they present a genuine medical paradox that practitioners and patients need to understand clearly while making treatment decisions with their oncology team.
High-dose chemotherapy is highly effective at destroying rapidly dividing cells — including cancer cells. But many of the agents used are simultaneously classified as carcinogens. They damage healthy immune cells, suppress bone marrow function, and — critically — can deplete the very natural healing capacity that determines whether a patient recovers afterward. This is precisely why supportive care to protect that capacity matters, rather than a reason to decline the treatment.
The paradox is not theoretical. Clinically, we see it regularly: a patient completes a chemotherapy course, scans show tumor reduction, and yet the patient struggles to recover — immune system compromised, gut microbiome disrupted, energy reserves exhausted. The lesson is not to avoid the protocol but to protect the host through it, so the biological resilience needed to sustain recovery is still intact when treatment ends.
4. From Conquest to Coexistence: The Emerging Paradigm
The language of oncology is slowly changing. The rhetoric of “going to war” with cancer is giving way — in the research literature if not yet in clinical culture — to frameworks of management, chronicity, and sustainable control. This shift reflects real clinical and biological insight:
- Controlling rather than eradicating: for some cancers, the goal of eliminating every cancer cell requires treatment intensities that heavily burden quality of life and immune capacity. In those settings, managing tumor burden to a level that does not threaten vital organ function — while preserving the patient’s reserves — is increasingly recognized as a legitimate goal. (For many other cancers, curative-intent eradication remains the right goal; which applies is a decision for the oncology team.)
- Targeted and immunological approaches: precision oncology and immunotherapy represent exactly this shift in practice. Rather than saturating the body with cytotoxic agents, these approaches engage the body’s own immune system or target cancer-specific molecular pathways while sparing healthy tissue.
- Host-centric care: the tumor microenvironment — the biological community surrounding a cancer — is now understood to be as important as the cancer cells themselves. A microenvironment that supports immune surveillance can help contain cancer; a depleted one cannot. Strengthening the host is not a rival to treatment; it is part of it.
From the perspective of Korean medicine, this convergence is not surprising. The classical principle that we treat the person, not the disease — 치인불치병(治人不治病) — has always prioritized systemic resilience alongside pathogen-specific elimination. Modern oncology is arriving at a similar conclusion through a different route.
5. What This Means for Patients: Practical Implications
The coexistence framework is not passive. It does not mean accepting cancer without treatment or abandoning evidence-based medicine. It means integrating two simultaneous objectives: addressing the tumor through the oncology team’s recommended treatment, and preserving the biological conditions that make recovery possible.
In my clinical experience, the patients who navigate this most effectively tend to share several characteristics:
- They treat sleep as a non-negotiable medical priority — not a luxury to sacrifice for treatment schedules.
- They maintain nutritional adequacy even during treatment, understanding that the body cannot repair itself without adequate substrate.
- They manage psychological stress actively, recognizing that chronic cortisol elevation suppresses immune function.
- They engage in gentle, consistent physical activity appropriate to their condition — not to “fight” cancer, but to maintain the metabolic and circulatory conditions that support immune function.
- They work with practitioners who view Korean medicine and conventional oncology as complementary rather than competing — using herbal support, acupuncture, and constitutional medicine to sustain resilience through treatment, in coordination with their oncology team.
6. The Constitutional Dimension: Why Patients Respond Differently
One of the most clinically significant observations in integrative oncology is the enormous variability in treatment response and recovery. Two patients with identical diagnoses, stages, and treatment protocols can have radically different outcomes. Conventional medicine explains this partly through genetics and tumor biology. Korean medicine offers an additional layer: constitutional type.
The Eight Constitution Medicine framework that I apply in clinical practice suggests that individuals differ in their organ system hierarchy and energetic vulnerabilities. A Taeyang constitution and a Soeum constitution may respond differently to the same chemotherapy protocol — not just in side effects, but in their capacity to mobilize recovery. Identifying constitutional type allows for personalized supportive interventions that conventional oncology, by design, is not structured to provide.
This is not mysticism. It is pattern-based medicine with a long empirical foundation — one that modern precision medicine is beginning to approach from a genomic direction.
7. A Diagnosis Is Not a Verdict
The most important reframe I offer patients is this: a cancer diagnosis is information about the current state of your biological system. It is not a verdict about your future. The body that produced the cancer is the same body that contains the resources to manage it. Those resources can be depleted — by chronic stress, by nutritional neglect, by the toll of treatment — or they can be protected and supported.
The patients I have watched recover with dignity and vitality are not those who fought hardest against their cancer. They are those who understood most clearly that healing and treatment are not the same thing — and who invested in both simultaneously, in partnership with their oncology team.
Medicine provides the tools. The healing capacity resides within you. The task of good oncology — integrative or conventional — is to ensure that capacity is still intact when it is needed most.
This article reflects the clinical observations and ongoing research of Professor Seungho Baek, Professor of Korean Medicine at Dongguk University College of Korean Medicine, specializing in Pathology and Oncology.
